Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey(University of Oxford), Angela M. Minassian(National Institute for Health and Care Research), Ian Hirsch(AstraZeneca (United Kingdom)), Brian Angus(University of Oxford), Vincenzo Libri, Helen Hill(Liverpool School of Tropical Medicine), Lily Yin Weckx(Hospital São Paulo), Gaurav Kwatra(South African Medical Research Council), Shuo Feng(University of Oxford), Eva Galiza(St George's, University of London), Thomas C. Darton(Sheffield Teaching Hospitals NHS Foundation Trust), Richard P. Marshall(GlaxoSmithKline (United Kingdom)), Carina C. D. Joe(University of Oxford), Anna L. Goodman(St Thomas' Hospital), Paola Cicconi(University of Oxford), Elizabeth Clutterbuck(University of Oxford), Carmen Briner(South African Medical Research Council), Katie Ewer(University of Oxford), Adam Finn(University of Bristol), Alane Izu(Wits University Donald Gordon Medical Centre), Parvinder K. Aley(University of Oxford), Shaun Barnabas(University of Cape Town), Christina Dold(University of Oxford), Daniela M. Ferreira(Liverpool School of Tropical Medicine), Vicky L. Baillie(South African Medical Research Council), Andrea M. Collins(Liverpool School of Tropical Medicine), Catherine Green(University of Oxford), Qasim Bhorat(Soweto CTC), Daniel Jenkin(University of Oxford), Sue Ann Costa Clemens(The George Institute for Global Health), Keertan Dheda(University of Cape Town), Katherine R. W. Emary(Churchill Hospital), Catherine Hill(Queen Elizabeth Hospital), Pedro M. Folegatti(University of Oxford), Natalie G. Marchevsky, Simon Kerridge(University of Oxford), Sagida Bibi(University of Oxford), Shabir A. Madhi(University of the Witwatersrand), Melanie Greenland(University of Oxford), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), C.J. Duncan(Newcastle University), Amy Flaxman(University of Oxford), Clare Cutland(University of the Witwatersrand), Patrick Lillie(Castle Hill Hospital), Lee Fairlie(University of the Witwatersrand), Christopher Green(UCSF Helen Diller Family Comprehensive Cancer Center), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Eveline Pı́polo Milan(Universidade Federal do Rio Grande do Norte), Anthonet Koen(University of the Witwatersrand), Rajeka Lazarus(University Hospitals Bristol NHS Foundation Trust)
Cited by 1,211
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k